Skip to main content
S. 2665 115th Congress Senate

A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and…

Official title: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug A… Show full official titleShow less

Official title: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.

Introduced: April 12, 2018 Introduced by: Todd Young Republican · Indiana See on congress.gov
Health Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substances
More subjectsShow fewer subjects
Drug, alcohol, tobacco useFood and Drug Administration (FDA)Government information and archivesHealth information and medical recordsMedical ethicsPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 12, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 12, 2018
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 12, 2018

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

This bill requires the Food and Drug Administration (FDA) to develop guidance regarding how it will assess evidence to support claims of opioid sparing (i.e., the use of drugs that reduce pain while also allowing reduced use or avoidance of oral opioids) for non-opioid or other non-addictive medical products intended to treat pain.

The FDA must also develop guidance regarding how it will consider the misuse and abuse of drugs in making certain determinations of safety.

 Related & companion bills 1
  • S 2680 Opioid Crisis Response Act of 2018
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.. 115th Congress. Open America. https://openamerica.io/bill/115-S-2665/
MLA
"S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2665/.
Bluebook (legal)
S. 2665, 115th Cong. (2026), https://openamerica.io/bill/115-S-2665/.
Markdown link
[S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.](https://openamerica.io/bill/115-S-2665/)
Report a problem